One study demonstrated nanomicelles that encapsulate siRNA-PD-L1 and combined them with HDAC inhibitors (HDACi) to effectively reverse T cell exhaustion and prevent the immune evasion of tumor cells. The gene discussed is HDAC9; the disease is neoplasm.